NO173825C - Analogifremgangsmaate for fremstilling av terapeutisk aktive carbaminsyreestere av substituerte 7-hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepiner - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive carbaminsyreestere av substituerte 7-hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepinerInfo
- Publication number
- NO173825C NO173825C NO890857A NO890857A NO173825C NO 173825 C NO173825 C NO 173825C NO 890857 A NO890857 A NO 890857A NO 890857 A NO890857 A NO 890857A NO 173825 C NO173825 C NO 173825C
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- halogen
- formula
- hydroxy
- substituted
- Prior art date
Links
- MHMRQHMKGYLQKH-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepin-7-ol Chemical class C1CNCCC2=CC(O)=CC=C21 MHMRQHMKGYLQKH-UHFFFAOYSA-N 0.000 title 1
- 229940112021 centrally acting muscle relaxants carbamic acid ester Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- -1 CN R<4> is H Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 abstract 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 abstract 1
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical group C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK107688A DK107688D0 (da) | 1988-03-01 | 1988-03-01 | Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO890857D0 NO890857D0 (no) | 1989-02-28 |
| NO890857L NO890857L (no) | 1989-09-04 |
| NO173825B NO173825B (no) | 1993-11-01 |
| NO173825C true NO173825C (no) | 1994-02-09 |
Family
ID=8100728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO890857A NO173825C (no) | 1988-03-01 | 1989-02-28 | Analogifremgangsmaate for fremstilling av terapeutisk aktive carbaminsyreestere av substituerte 7-hydroxy-2,3,4,5-tetrahydro-1H-3-benzazepiner |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5017571A (de) |
| EP (1) | EP0331130B1 (de) |
| JP (1) | JPH01254679A (de) |
| KR (1) | KR0126473B1 (de) |
| AT (1) | ATE95179T1 (de) |
| AU (1) | AU613716B2 (de) |
| CA (1) | CA1312863C (de) |
| DE (1) | DE68909448T2 (de) |
| DK (1) | DK107688D0 (de) |
| ES (1) | ES2059592T3 (de) |
| FI (1) | FI94955C (de) |
| IE (1) | IE64247B1 (de) |
| IL (1) | IL89207A0 (de) |
| NO (1) | NO173825C (de) |
| NZ (1) | NZ228151A (de) |
| PH (1) | PH26368A (de) |
| PT (1) | PT89887B (de) |
| ZA (1) | ZA891537B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
| AU666318B2 (en) * | 1991-06-28 | 1996-02-08 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5470850A (en) * | 1992-02-24 | 1995-11-28 | Novo Nordisk A/S | 2,3,4,5-tetrahydro-1H-3-benzazepines |
| MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
| US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
| US20030125317A1 (en) * | 1996-10-02 | 2003-07-03 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| US7704993B2 (en) | 2003-06-17 | 2010-04-27 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| US20080009478A1 (en) * | 2003-10-22 | 2008-01-10 | Arena Pharmaceuticals, Inc. | Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases |
| BRPI0515862A2 (pt) | 2004-12-23 | 2011-10-11 | Arena Pharm Inc | uso de fentermina e agonista seletivo do receptor de 5ht-2c na preparação de composições, composições moduladoras do receptor de 5ht-2c e forma de dosagem unitária compreendendo as mesmas |
| US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 수용체 아고니스트의 제조 방법 |
| KR20130138770A (ko) | 2010-09-01 | 2013-12-19 | 아레나 파마슈티칼스, 인크. | 광학적으로 활성 산을 갖는 로르카세린의 염 |
| SG188361A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
| US8999970B2 (en) | 2010-09-01 | 2015-04-07 | Arena Pharmaceuticals, Inc. | Administration of an anti-obesity compound to individuals with renal impairment |
| EP3485878A1 (de) | 2010-09-01 | 2019-05-22 | Arena Pharmaceuticals, Inc. | Darreichungsformen von 5-ht2c-agonisten, die nützlich für gewichtskontrolle sind |
| CA2886875A1 (en) | 2012-10-09 | 2014-04-17 | Arena Pharmaceuticals, Inc. | Method of weight management |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3393192A (en) * | 1965-04-26 | 1968-07-16 | Schering Corp | Novel benzazepines |
| US3609138A (en) * | 1967-12-22 | 1971-09-28 | Ciba Geigy Corp | 1-aryl-3-benzazepines |
| US4011319A (en) * | 1975-07-02 | 1977-03-08 | Smithkline Corporation | Pharmaceutical compositions and methods involving benzazepine derivatives |
| ZA792044B (en) * | 1978-05-08 | 1980-05-28 | Scherico Ltd | Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them |
| US4284555A (en) * | 1979-04-27 | 1981-08-18 | Schering Corporation | 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
| US4668685A (en) * | 1984-07-05 | 1987-05-26 | E.I. Du Pont De Nemours And Company | Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists |
| DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
| ZA882080B (en) * | 1987-03-27 | 1989-04-26 | Schering Corp | Substituted benzazepines,their preparation and pharmaceutical compositions containing them |
-
1988
- 1988-03-01 DK DK107688A patent/DK107688D0/da not_active Application Discontinuation
-
1989
- 1989-02-07 IL IL89207A patent/IL89207A0/xx not_active IP Right Cessation
- 1989-02-10 IE IE42089A patent/IE64247B1/en not_active IP Right Cessation
- 1989-02-14 CA CA000590992A patent/CA1312863C/en not_active Expired - Fee Related
- 1989-02-20 PH PH38219A patent/PH26368A/en unknown
- 1989-02-22 FI FI890841A patent/FI94955C/fi not_active IP Right Cessation
- 1989-02-25 KR KR1019890002236A patent/KR0126473B1/ko not_active Expired - Fee Related
- 1989-02-27 NZ NZ228151A patent/NZ228151A/xx unknown
- 1989-02-28 DE DE89103531T patent/DE68909448T2/de not_active Expired - Fee Related
- 1989-02-28 NO NO890857A patent/NO173825C/no unknown
- 1989-02-28 ZA ZA891537A patent/ZA891537B/xx unknown
- 1989-02-28 US US07/317,016 patent/US5017571A/en not_active Expired - Fee Related
- 1989-02-28 ES ES89103531T patent/ES2059592T3/es not_active Expired - Lifetime
- 1989-02-28 EP EP89103531A patent/EP0331130B1/de not_active Expired - Lifetime
- 1989-02-28 AT AT89103531T patent/ATE95179T1/de not_active IP Right Cessation
- 1989-03-01 PT PT89887A patent/PT89887B/pt not_active IP Right Cessation
- 1989-03-01 JP JP1046695A patent/JPH01254679A/ja active Pending
- 1989-03-01 AU AU30907/89A patent/AU613716B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA1312863C (en) | 1993-01-19 |
| NZ228151A (en) | 1991-08-27 |
| NO173825B (no) | 1993-11-01 |
| NO890857D0 (no) | 1989-02-28 |
| ZA891537B (en) | 1989-11-29 |
| KR0126473B1 (ko) | 1997-12-24 |
| NO890857L (no) | 1989-09-04 |
| ES2059592T3 (es) | 1994-11-16 |
| ATE95179T1 (de) | 1993-10-15 |
| JPH01254679A (ja) | 1989-10-11 |
| IE890420L (en) | 1989-09-01 |
| US5017571A (en) | 1991-05-21 |
| DE68909448T2 (de) | 1994-02-10 |
| EP0331130B1 (de) | 1993-09-29 |
| AU613716B2 (en) | 1991-08-08 |
| KR890014494A (ko) | 1989-10-24 |
| DE68909448D1 (de) | 1993-11-04 |
| AU3090789A (en) | 1989-09-07 |
| PH26368A (en) | 1992-06-01 |
| FI94955B (fi) | 1995-08-15 |
| FI94955C (fi) | 1995-11-27 |
| EP0331130A1 (de) | 1989-09-06 |
| DK107688D0 (da) | 1988-03-01 |
| FI890841A7 (fi) | 1989-09-02 |
| FI890841A0 (fi) | 1989-02-22 |
| IL89207A0 (en) | 1989-09-10 |
| IE64247B1 (en) | 1995-07-26 |
| PT89887A (pt) | 1989-11-10 |
| PT89887B (pt) | 1994-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI890841A0 (fi) | Menetelmä uusien terapeuttisesti aktiivisten substituoitujen 7-hydroksi-2,3,4,5-tetrahydro-1H-3-bentsatsepiinien karbamiinihappoestereiden valmistamiseksi | |
| DE68920773D1 (de) | Chinoloncarbonsäure-Derivate. | |
| FI892787A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi | |
| EP0675878A1 (de) | Neuen vitamin d derivate. | |
| ES549979A0 (es) | Procedimiento para preparar nuevas pirrolidina-2,5-dionas espiroenlazadas | |
| NO880964D0 (no) | Analogifremgangsmaate for fremstilling av anticancer legemiddel. | |
| NO845147L (no) | Fremgangsmaate for fremstilling av forbindelser med anti-psoriasis-aktivitet | |
| DE69021101D1 (de) | Imidazochinolon-Derivate. | |
| ES2070522T3 (es) | Compuestos anti-inflamatorios. | |
| DE3787844D1 (de) | Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen. | |
| NO894384D0 (no) | Forbindelser for behandling av urininkontinens. | |
| FR2709489B1 (fr) | Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| FI850325L (fi) | Antipsoriatiska naftalener. | |
| ATE28639T1 (de) | Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung. | |
| DK87689A (da) | Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner | |
| NO162859C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksadiazolylimidazobenzodiazepinforbindelser. | |
| DE69120348D1 (de) | Cyclopropachromenderivate | |
| ATE160144T1 (de) | Pyridazinon derivate, herstellungsverfahren und verwendung | |
| NO885412D0 (no) | Nye terapeutisk aktive forbindelser og fremgangsmaate for deres fremstilling. | |
| ES2051722T3 (es) | Procedimiento para estabilizar derivados de procaterol. | |
| ATE131057T1 (de) | 8-chloro-benzothiazepin-verbindung zur prophylaxe und behandlung der folgen der zerebralen nekrose von neurozyten. |